Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v14-EN Version v12-EN
Language English English
Date Updated 2019-08-01 2018-12-17
Drug Identification Number 02428474 02428474
Brand name SEPTA-ZOLMITRIPTAN-ODT SEPTA-ZOLMITRIPTAN-ODT
Common or Proper name Zolmitriptan Orally Disintegrating tablets Zolmitriptan Orally Disintegrating tablets
Company Name SEPTA PHARMACEUTICALS INC SEPTA PHARMACEUTICALS INC
Ingredients ZOLMITRIPTAN ZOLMITRIPTAN
Strength(s) 2.5MG 2.5MG
Dosage form(s) TABLET (ORALLY DISINTEGRATING) TABLET (ORALLY DISINTEGRATING)
Route of administration ORAL ORAL
Packaging size 6s 6s
ATC code N02CC N02CC
ATC description ANTIMIGRAINE PREPARATIONS ANTIMIGRAINE PREPARATIONS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-06-27 2017-06-27
Estimated end date Unknown Unknown
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments